This success is particularly noteworthy given the historically limited efficacy of immunotherapy in OC [74,75], underscoring the critical interplay between Ubr5 and the immune system in regulating tumor growth and Immunotherapy response. This evidence concerns the gene UBR5 and neoplasm.